Tag: US Securities and Exchange Commission (SEC)

Bryn Pharma Intranasal Epinephrine Device

Bryn Pharma Raises Another $15 Million for Commercialization of Needle-Free Intranasal...

Company is developing UTULY for intranasal emergency epinephrine delivery.

Mylan to Pay $30 Million for Disclosure and Accounting Failure Relating...

Mylan agreed to pay $30 million to settle charges they overcharged Medicaid hundreds of millions of dollars for EpiPen.
Windgap-ANDI

Developer of Revolutionary "Powder" Epinephrine Auto-Injector Raises $12 Million

Windgap Medical is securing funding to continue development.
AR101 Delayed by Gov't Shutdown

Government Shutdown Delays Review of AR101 Peanut Oral Immunotherapy Candidate

The FDA has shelved consideration of the drug until funding is restored.
Mylan

Department of Justice Investigating Mylan Regarding Trade Compliance for Certain Products

Manufacturer of EpiPen complies with DOJ requests and warrant issued by a special prosecutor's office in Milan, Italy.
Dinner Out

Food Allergen Detector Draws $20 Million in Venture Funding

The device joins others intended for use as portable "point of consumption" testers.